Bayesian Capital Management, LP Nuvasive Inc Transaction History

Bayesian Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$32.82 - $81.13 $423,378 - $1.05 Million	-12,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.96 - $77.7 $786,384 - $1 Million	12,900 New	12,900 $998,000
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $601,427 - $800,684	-13,066 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$50.58 - $60.79 $660,878 - $794,282	13,066	13,066 $764,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.